Biomarin Pharmaceutical
Aktie
WKN: 924801 ISIN: US09061G1013
+++++++++++++++++++++++++++++++++
Zitat:
|
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I), by manufacturing laronidase (Aldurazyme, commercialized by Genzyme Corporation). BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU).[2][3]
|
Quelle am 08.07.2020:
https://en.wikipedia.org/wiki/BioMarin_Pharmaceutical
+++++++++++++++++++++++++++++++++
Internet: www.biomarinpharm.com
News: https://www.finanznachrichten.de/nac...utical-inc.htm
Shorts nur von Morgan Stanley 
In US-$:
Unten: Daily, Stand 08.07.2020:
Das Teil könnte jetzt für eine ganze Weile "oben" gewesen sein!
